Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0cb28b75c0907a8b523a1f747ca6a5cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bef96a52ca9eaf6230a857ba74af9a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3762acd0de9ca20b29f3bc7263eeb4de http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cae9ac055d225497789e01b5f45ac753 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_020a3ddedcd48d34f28f92e3d74831aa |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16622 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-035 |
filingDate |
1994-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4cdcff4a14ce0cfed1a2c187b995dc8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0255fee57a303ba7f4b6d5f644ab43a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_654b3f64270214f25f84560e9f5f84ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c953cb4f7bbd675fa7a3b11cb1394f9f |
publicationDate |
2001-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9516779-A9 |
titleOfInvention |
Herpes-symplex-virus type 2 icp4 protein and its use in a vaccine composition |
abstract |
Immediate early HSV-2 viral protein ICP4 recognised by cytolytic T-lymphocyte (CTL) cells in humans, methods for preparation thereof and use in vaccine. |
priorityDate |
1993-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |